Skip to main content
Premium Trial:

Request an Annual Quote

FDA Recommends Genotyping (But Not for Finding Your Soul Mate)

Over at PatentDocs, Kevin Noonan writes about a genotyping advisory that was included in a black box warning from FDA for abacavir, a GlaxoSmithKline drug used in HIV and AIDS treatment. Research has shown that patients with the HLA-B*5701 variant are significantly more likely to have a potentially life-threatening allergic reaction to the drug. Here's an excerpt from the FDA's advisory: "All patients should be screened for the HLA-B*5701 allele before starting or restarting treatment with abacavir or abacavir-containing medications."


The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.